DNB Carnegie acted as sole global coordinator and sole bookrunner in the fully guaranteed rights issue of SEK 52 million in combination with directed share issue of SEK 16 million in Ortoma.
Ortoma is a medtech company developing AI driven solutions for orthopedic surgery. Its flagship product, OTS Hip, supports surgeons in hip replacements through personalized 3D pre operative planning, automated implant recommendations, motion analysis, and precise implant positioning via a real time navigation system. The solution fits seamlessly into standard surgical workflows. OTS Hip is already launched with strong uptake in Japan and is preparing for EU and US commercialization, where it is regulatory cleared. Ortoma focuses on development and manufacturing, while commercial rollout will be driven by its strategic partner Johnson & Johnson, providing validation and broad market access.